Investigation and intervention of donor-derived infection of renal transplantation

doi:10.3969/j.issn.1006-7795.2019.05.019

Abstract

Abstract: Objective To summarize the experience of donor selection and receptor therapy in the face of potential donor infection, which improves the quality of the use of donor organs, reduces the risk of postoperative infection and the loss of transplant kidney and recipient mortality. Methods This study used a retrospective analysis of 59 kidneys from 31 donors and corresponding recipients from April 2017 to March 2018. Results The pathogenic culture of only 10 donors in 31 donors were totally negative, accounting for only 32%. Two receptors whose donor's blood culture was positive for Acinetobacter baumannii were treated with cefoperazone sulbactam sodium and tigecycline; two receptors whose donor's phlegm culture was positive for Acinetobacter baumannii were treated with cefoperazone sulbactam sodium; for the donor whose phlegm culture was positive for Candida albicans, the responding recipient whose urine culture was positive for the same pathogenic bacteria was treated with fluconazole; none of the above recipients experienced serious adverse events caused by donor-derived infections after targeted anti-infective treatment. Conclusion Although it is quite common for the donor to have an infection before the organ is acquired, we could improve prognosis of the patients and reduce the serious adverse events caused by donor-derived infections through a package of measures, such as target and preventive application of appropriate and prophylactic antibiotics to the corresponding donors, closely detecting changes in infection indicators, and adjusting medications timely.

Key words: kidney transplantation, donor-derived infection, cefoperazone sulbactam sodium, acinetobacter baumannii, candida albicans

CLC Number:

Shan Hui, Zhang Xin, Gu Li, Tang Ziren, Zhang Xiaodong. Investigation and intervention of donor-derived infection of renal transplantation[J]. Journal of Capital Medical University, 2019, 40(5): 764-768.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2019.05.019

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2019/V40/I5/764

References

[1] Fishman J A, Grossi P A. Donor-derived infection-the challenge for transplant safety[J]. Nat Rev Nephrol,2014,10(11):663-672.
[2] 中华医学会器官移植学分会,中华预防医学会医院感染控制学分会,复旦大学华山医院抗生素研究所. 中国实体器官移植供者来源感染防控专家共识(2018版)[J]. 中华器官移植杂志,2018,39(1):41-52.
[3] 王飞飞,屠振华. 实体器官移植供者来源感染[J]. 实用器官移植电子杂志,2018,6(1):65-69.
[4] 朱有华. DCD供者来源感染现状与防控策略[J]. 实用器官移植电子杂志,2018,6(1):49-50.
[5] van Duin D, van Delden C, AST Infectious Disease Community of Practive. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation[J]. Am J Transplant,2013,13 Suppl 4:31-41.
[6] Lin J, Wang R, Chen J. Tigecycline-induced acute pancreatitis in a renal transplant patient:a case report and literature review[J]. BMC Infect Dis,2018,18(1):201.
[7] Gomez C A, Singh N. Donor-derived filamentous fungal infections in solid organ transplant recipients[J]. Curr Opin Infect Dis,2013,26(4):309-316.
[8] Chow E K, Massie A B, Muzaale A D, et al. Identifying appropriate recipients for CDC infectious risk donor kidneys[J]. Am J Transplant,2013,13(5):1227-1234.
[9] Giani T, Conte V, Mandala S, et al. Cross-Infection of solid organ transplant recipients by a multidrug-resistant klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor[J]. J Clin Microbiol,2014,52(7):2702-2705.
[10] Fischer S A, Lu K, AST Infectious Disease Community of Practive. Screening of donor and recipient in solid organ transplantation[J]. Am J Transplant,2013,13 Suppl 4:9-21.
[11] Kirchner V A, Pruett T L. Receiving the unwanted gift:infection transmission through organ transplantation[J]. Surg Infect,2016,17(3):318-322.
[12] Schwartz B S, Mawhorter S D. Parasitic infections in solid organ transplantation[J]. Am J Transplant,2013,13 Suppl 4:280-303.
[13] Le M, Ravin K, Hasan A, et al. Single donor-derived strongyloidiasis in three solid organ transplant recipients:case series and review of the literature[J]. Am J Transplant,2014,14(5):1199-1206.
[14] 吴佳晋,应亮,李大伟,等. 肾移植供体来源耐药肺炎克雷伯杆菌感染13例救治经验[J]. 实用器官移植电子杂志,2018,6(1):9-12.
[15] Ison M G, Grossi P, AST Infectious Disease Community of Practive. Donor-derived infections in solid organ transplantation[J]. Am J Transplant,2013,13 Suppl 4:22-30.